The molecular epidemiology of ethambutol-resistant Mycobacterium tuberculosis in Henan Province, China

Japanese Journal of Infectious Diseases

Volumn 58, Issue 6, 2005, Pages 393-395

  Sugawara, Isamu ^a   Otomo, Koji ^a   Yamada, Hiroyuki ^a   Wang, Guobin ^b   Du, Changmei ^b   Shi, Ruiru ^b   Zhang, Guolong ^b  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b Henan Chest Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGE DISTRIBUTION; AMPLICON; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; CODON; CONTROLLED STUDY; DNA PURIFICATION; DNA SEQUENCE; DRUG ABUSE; FEMALE; GENE AMPLIFICATION; HEALTH EDUCATION; HUMAN; INCIDENCE; INFORMATION PROCESSING; MALE; MISSENSE MUTATION; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPERON; POINT MUTATION; POLYMERASE CHAIN REACTION; PRESCRIPTION; SEX RATIO; SHORT COURSE THERAPY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 30544448158     PISSN: 13446304     EISSN: 13446304     Source Type: Journal    
DOI: 10.7883/yoken.jjid.2005.393     Document Type: Article

References (11)

1. Sreevatsan, S. S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L., Jacobs, W. R., Telenti, A. and Musser, J. M. (1997). EMB resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob. Agents Chemother., 41, 1677-1681.
2. Ramaswamy, S. V., Amin, A. G., Goksel, S., Stager, C. E., Dou, S. J., El Sahly, H., Moghazeh, S, L., Kreiswirth, B. N. and Musser, J. M. (2000): Molecular genetic analysis of nucleotide polymorphisms associated with EMB resistance in human isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 44, 326-336.
3. Lee, H. Y., Myoung, H. J., Bang, H. E., Bai, G. H., Kim, S. J., Kim, J. D. and Cho, S. N. (2002): Mutations in the embB locus among Korean clinical isolates of Mycobacterium tuberculosis resistant to EMB. Yonsei Med. J., 43, 59-64.
4. Mokrousov, I., Otten, T., Vyshnevskiy, B. and Narvskaya, O. (2002): Detection of embB 306 mutations in EMB-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: implications for genotypic resistance testing. J. Clin. Microbiol., 40, 3810-3813.
5. Belanger, A. E., Besra, G. S., Ford, M. E., Mikusova, K., Belisle, J. T., Brennan, P. J. and Inamine, J. M. (1996): The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinogalactan biosynthesis that is the target for the antimycobacterial drug EMB. Proc. Natl. Acad. Sci. USA, 93, 11919-11924.
6. Telenti, A., Philipp, W. J., Sreevatsan, S., Bernasconi, C., Stockbauer, K. E., Wieles, B., Musser, J. M. and Jacobs, W. R. (1997): The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to EMB. Nature Med., 3, 567-570.
7. Sugawara, I., Yamada, H., Kazumi, Y., Doi, N., Otomo, K., Aoki, T., Mizuno, S., Udagawa, T., Tagawa, Y. and Iwakura, Y. (1998): Induction of granulomas in IFN- γ gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis. J. Med. Microbiol., 47, 871-877.
8. Victor, T. C., Jordaan, A. M., van Rie, A., van der Spuy, G. D., Richardson, M., van Helden, P. D. and Warren, R. (1999): Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuber. Lung Dis., 79, 343-348.
9. Dolin, P. J., Raviglione, M. C. and Kochi, A. (1994): Global tuberculosis incidence and mortality during 1990-2000. Bull. World Health Org., 72, 213-220.
10. Cooksey, R. C., Morlock, G. P., Holloway, B. P., Limor, J. and Hepburn, M. (2002): Temperature-mediated heteroduplex analysis performed by using denaturing high-performance liquid chromatography to identify sequence polymorphisms in Mycobacterium tuberculosis complex organisms. J. Clin. Microbiol., 40, 1610-1616.
11. Shi, R., Otomo, K., Yamada, H., Tatsumi, T. and Sugawara, I.: Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease. Microbes Infect. (in press).